• 866 Citations
  • 18 h-Index
19992018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Chiara Matilde Catania is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
gemcitabine Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Cisplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2018

  • 866 Citations
  • 18 h-Index
  • 63 Article
  • 1 Review article
3 Citations (Scopus)

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer

Toffalorio, F., Santarpia, M., Radice, D., Jaramillo, C. A., Spitaleri, G., Manzotti, M., Catania, C., Jordheim, L. P., Pelosi, G., Peters, G. J., Tibaldi, C., Funel, N., Spaggiari, L., de Braud, F., De Pas, T. & Giovannetti, E., Jan 1 2018, In : Oncotarget. 9, 23, p. 16437-16450 14 p.

Research output: Contribution to journalArticle

gemcitabine
5'-Nucleotidase
Combination Drug Therapy
Platinum
Non-Small Cell Lung Carcinoma

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer

Toffalorio, F., Santarpia, M., Radice, D., Jaramillo, C. A., Spitaleri, G., Manzotti, M., Catania, C., Jordheim, L. P., Pelosi, G., Peters, G. J., Tibaldi, C., Funel, N., Spaggiari, L., de Braud, F., De Pas, T. & Giovannetti, E., Mar 27 2018, In : Oncotarget. 9, 23, p. 16437-16450 14 p.

Research output: Contribution to journalArticle

gemcitabine
5'-Nucleotidase
Combination Drug Therapy
Platinum
Non-Small Cell Lung Carcinoma

Afraid That I'll Not Be Afraid-A Paradox of Care

Catania, C., Nov 1 2017, In : JAMA oncology. 3, 11, p. 1469-1470 2 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Brigatinib for the treatment of ALK-positive advanced non-small cell lung cancer patients

Passaro, A., Prelaj, A., Pochesci, A., Spitaleri, G., Rossi, G., Del Signore, E., Catania, C. & De Marinis, F., Aug 1 2017, In : Drugs of Today. 53, 8, p. 435-446 12 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Clinical Trials
Therapeutics
anaplastic lymphoma kinase
2 Citations (Scopus)
Non-Small Cell Lung Carcinoma
Drug Delivery Systems
Disease Progression
Phosphotransferases
Clinical Trials